STAHLBERG JAN bought DMAC
November 21, 2025 · Form 4 insider transaction
STAHLBERG JAN bought 208,872 shares of DiaMedica Therapeutics Inc. at $7.41 per share, a transaction worth $1.55M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 17 days after the transaction.
Direction
Acquired (buy-side)
Shares
208,872
Price
$7.41
Total value
$1.55M
InsiderSTAHLBERG JAN
Role—
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateNovember 21, 2025
Filing dateDecember 8, 2025
Shares owned after8,712,390
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.